3 ·Filed Jun 10, 2026

VIR

Vir Biotechnology, Inc.
NEUTRAL
Impact 1/10
Horizonmonths Processed3mo ago SEC0001628280-26-042325
Form 3 — initial insider ownership statement
Actionable Insight • Neutral

No trading signal from this filing. Monitor future Form 4 filings from Coughlin for any insider buying or selling activity. Given the zero-share initial filing, any future open-market purchase would be a clean insider-buy signal to track.

DirectionNeutral
Confidencehigh
Horizonmonths
Latest settled — T+20d ⚠ clustered
VIR ▲ +21.36% at T+20d
NEUTRAL call ✓ call won +21.36% · α vs SPY +19.47% · entry $8.52 → $10.34
Next anchor: T+60d due 28d ago
Latest observation: T+57 +59.22% FF3 residual α
Entry anchored
Jun 10, 03:59 PM ET
via exchange tick
T+1d
+1.06%
call +1.06% · α +0.52%
$8.61
settled 4mo ago
T+5d
+9.15%
call +9.15% · α +8.72%
$9.30
settled 4mo ago
T+20d
+21.36%
call +21.36% · α +19.47%
$10.34
settled 3mo ago
T+60d
—
call — · α —
—
due 28d ago

Price Chart

Loading chart...

Executive Summary

Timothy Coughlin filed a Form 3 initial statement of beneficial ownership with the SEC, reporting zero shares of Vir Biotechnology common stock. This is a routine filing for a new Section 16 reporting person who has no current holdings, and carries no material trading or financial signal.

Key Facts

  • Form 3 filed by Timothy Coughlin as a new Section 16 reporting person on June 10, 2026
  • Filing reports 0 shares of common stock beneficially owned as of June 9, 2026
  • A power of attorney was also filed, authorizing certain individuals to execute Section 16 filings on Coughlin's behalf

Financial Impact

No financial impact — zero shares reported, no transaction activity.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (14 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001628280-26-042325
Document: 0001628280-26-042325-index-headers.html0001628280-26-042325
Document: 0001628280-26-042325-index.html0001628280-26-042325
Document: 0001628280-26-042325.txt0001628280-26-042325
18 reports for VIR
Performance horizon
40% Hit rate 2 of 5 directional calls best @ T+60▲ +10.12%Feb 24, 2026
Filters
Rows
Reports for VIR — sortable, filterable
TypeNow
Aug 14, 2026
7w ago
Court Ruling
NEUTRAL ★ 1/10
$9.24 $9.78▲ +5.84%▲ +7.21%$11.17 (+20.89%)
Aug 9, 2026
7w ago
Institutional Cluster
BULLISH ★ 5/10
$8.89 $9.39▲ +5.62%▲ +5.67%$11.17 (+25.65%)
Jul 24, 2026
10w ago
8-K
NEUTRAL ★ 3/10
$8.69 $8.90▲ +2.42%▲ +2.04%$11.17 (+28.54%)
Jun 29, 2026
13w ago
144
NEUTRAL ★ 2/10
$10.38 $10.02▼ −3.47%▼ −4.86%$11.17 (+7.61%)
Jun 10, 2026
16w ago
3
NEUTRAL ★ 1/10
$8.52 $9.30▲ +9.15%▲ +8.72%$11.17 (+31.10%)
Jun 10, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$8.52 $9.30▲ +9.15%▲ +8.72%$11.17 (+31.10%)
Jun 2, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$8.77 $8.25▼ −5.93%▼ −2.11%$11.17 (+27.37%)
May 28, 2026
18w ago
8-K
NEUTRAL ★ 2/10
$9.55 $8.77▼ −8.17%▼ −8.12%$11.17 (+16.96%)
Apr 16, 2026
24w ago
DEFA14A
NEUTRAL ★ 3/10
$10.33 $10.35▲ +0.19%▼ −0.79%$11.17 (+8.13%)
Apr 10, 2026
25w ago
8-K
NEUTRAL ★ 3/10
$9.31 $11.09▲ +19.12%▲ +15.82%$11.17 (+19.98%)
Showing 10 of 18

US Market Status

Market Closed — Opens Mon (64h 10m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access